Literature DB >> 21864209

Sterol profiles in plasma and erythrocyte membranes in patients with Smith-Lemli-Opitz syndrome: a six-year experience.

Gaetano Corso1, Monica Gelzo, Rosalba Barone, Stefano Clericuzio, Pierluigi Pianese, Angela Nappi, Antonio Dello Russo.   

Abstract

BACKGROUND: This study reports our experience over the last six years in the diagnosis of Smith-Lemli-Opitz syndrome and other inborn errors of cholesterol biosynthesis.
METHODS: Gas chromatography/mass spectrometry was used to obtain sterol profiles in plasma and erythrocyte membranes of suspected patients.
RESULTS: Plasma sterol reference values calculated in unaffected subjects (n=276) were in agreement with those previously reported. Among patients investigated from 2005 to 2010, we report 16 patients affected by Smith-Lemli-Opitz syndrome, three of whom represent new cases and 13 of whom were follow-up patients. In this period we also identified a new case of chondrodysplasia punctata 2 X-linked. The estimated incidence obtained for Smith-Lemli-Opitz syndrome was 1:93 suspected patients (1.08%). We also studied the effect of storage on the dehydrocholesterols/cholesterol ratio in plasma and erythrocyte membranes of patients affected by Smith-Lemli-Opitz syndrome stored at -20°C for up to 22 and 20 months, respectively. A significant negative linear correlation between storage time and the dehydrocholesterols/cholesterol ratio was identified in both plasma and erythrocyte membranes. The decrease in the dehydrocholesterols/cholesterol ratio in erythrocyte membranes was at least two-fold higher than in plasma.
CONCLUSIONS: The results of this study may be helpful for diagnosis and interpretation of data in patients with findings suggestive of a cholesterol biosynthesis defect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864209     DOI: 10.1515/CCLM.2011.689

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports.

Authors:  Maria Donata Di Taranto; Monica Gelzo; Carola Giacobbe; Marco Gentile; Gennaro Marotta; Silvia Savastano; Antonio Dello Russo; Giuliana Fortunato; Gaetano Corso
Journal:  Metab Brain Dis       Date:  2016-05-26       Impact factor: 3.584

2.  7DHC-induced changes of Kv1.3 operation contributes to modified T cell function in Smith-Lemli-Opitz syndrome.

Authors:  András Balajthy; Sándor Somodi; Zoltán Pethő; Mária Péter; Zoltán Varga; Gabriella P Szabó; György Paragh; László Vígh; György Panyi; Péter Hajdu
Journal:  Pflugers Arch       Date:  2016-06-17       Impact factor: 3.657

3.  Liver and the defects of cholesterol and bile acids biosynthesis: Rare disorders many diagnostic pitfalls.

Authors:  Gaetano Corso; Antonio Dello Russo; Monica Gelzo
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

4.  Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study.

Authors:  Felice Amato; Alice Castaldo; Giuseppe Castaldo; Gustavo Cernera; Gaetano Corso; Eleonora Ferrari; Monica Gelzo; Romina Monzani; Valeria Rachela Villella; Valeria Raia
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

5.  Severe Genotype, Pancreatic Insufficiency and Low Dose of Pancreatic Enzymes Associate with Abnormal Serum Sterol Profile in Cystic Fibrosis.

Authors:  Sławomira Drzymała-Czyż; Patrycja Krzyżanowska-Jankowska; Krzysztof Dziedzic; Aleksandra Lisowska; Szymon Kurek; Joanna Goździk-Spychalska; Victoria Kononets; Dagmara Woźniak; Edyta Mądry; Jarosław Walkowiak
Journal:  Biomolecules       Date:  2021-02-19

6.  Age-related changes of cholestanol and lathosterol plasma concentrations: an explorative study.

Authors:  Monica Gelzo; Maria Donata Di Taranto; Concetta Sica; Antonio Boscia; Francesco Papagni; Giuliana Fortunato; Gaetano Corso; Antonio Dello Russo
Journal:  Lipids Health Dis       Date:  2019-12-30       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.